Benzinga's Top Upgrades, Downgrades For October 28, 2020

Benzinga的頂級升級，2020年10月28日的降級

Benzinga Real-time News · 2020/10/28 12:38

Upgrades

For Omnicom Group Inc (NYSE:OMC), MoffettNathanson upgraded the previous rating of Sell to the current rating Neutral. Omnicom Group earned $1.21 in the third quarter, compared to $1.32 in the year-ago quarter. At the moment, the stock has a 52-week-high of 82.73 and a 52-week-low of 46.37. Omnicom Group closed at $48.81 at the end of the last trading period.
For Advanced Micro Devices Inc (NASDAQ:AMD), Craig-Hallum upgraded the previous rating of Hold to the current rating Buy. For the third quarter, Advanced Micro Devices had an EPS of $0.41, compared to year-ago quarter EPS of $0.18. At the moment, the stock has a 52-week-high of 94.28 and a 52-week-low of 31.83. Advanced Micro Devices closed at $78.88 at the end of the last trading period.
B. Riley FBR upgraded the previous rating for ViewRay Inc (NASDAQ:VRAY) from Neutral to Buy. For the second quarter, ViewRay had an EPS of $0.18, compared to year-ago quarter EPS of $0.32. The current stock performance of ViewRay shows a 52-week-high of 4.88 and a 52-week-low of 1.1055. Moreover, at the end of the last trading period, the closing price was at $3.00.
Deutsche Bank upgraded the previous rating for Lululemon Athletica Inc (NASDAQ:LULU) from Hold to Buy. For the second quarter, Lululemon Athletica had an EPS of $0.74, compared to year-ago quarter EPS of $0.96. The stock has a 52-week-high of 399.8965 and a 52-week-low of 128.845. At the end of the last trading period, Lululemon Athletica closed at $333.81.
According to JP Morgan, the prior rating for Xilinx Inc (NASDAQ:XLNX) was changed from Underweight to Neutral. Xilinx earned $0.79 in the second quarter, compared to $0.94 in the year-ago quarter. The stock has a 52-week-high of 130.4 and a 52-week-low of 67.68. At the end of the last trading period, Xilinx closed at $124.35.
JP Morgan upgraded the previous rating for Sherwin-Williams Co (NYSE:SHW) from Neutral to Overweight. In the third quarter, Sherwin-Williams showed an EPS of $8.29, compared to $6.65 from the year-ago quarter. The current stock performance of Sherwin-Williams shows a 52-week-high of 725.91 and a 52-week-low of 325.43. Moreover, at the end of the last trading period, the closing price was at $673.04.
For MSC Industrial Direct Co Inc (NYSE:MSM), Raymond James upgraded the previous rating of Underperform to the current rating Market Perform. In the fourth quarter, MSC Industrial Direct Co showed an EPS of $1.09, compared to $1.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of 79.87 and a 52-week-low of 44.93. MSC Industrial Direct Co closed at $67.72 at the end of the last trading period.
Barclays upgraded the previous rating for First Solar Inc (NASDAQ:FSLR) from Underweight to Equal-Weight. First Solar earned $1.45 in the third quarter, compared to $0.29 in the year-ago quarter. The stock has a 52-week-high of 87.44 and a 52-week-low of 28.47. At the end of the last trading period, First Solar closed at $82.39.
For Advanced Micro Devices Inc (NASDAQ:AMD), Barclays upgraded the previous rating of Equal-Weight to the current rating Overweight. For the third quarter, Advanced Micro Devices had an EPS of $0.41, compared to year-ago quarter EPS of $0.18. The current stock performance of Advanced Micro Devices shows a 52-week-high of 94.28 and a 52-week-low of 31.83. Moreover, at the end of the last trading period, the closing price was at $78.88.
According to Keefe, Bruyette & Woods, the prior rating for Invesco Ltd (NYSE:IVZ) was changed from Market Perform to Outperform. For the third quarter, Invesco had an EPS of $0.53, compared to year-ago quarter EPS of $0.70. The stock has a 52-week-high of 19.01 and a 52-week-low of 6.375. At the end of the last trading period, Invesco closed at $13.96.

Downgrades

According to Craig-Hallum, the prior rating for Enphase Energy Inc (NASDAQ:ENPH) was changed from Buy to Hold. For the third quarter, Enphase Energy had an EPS of $0.30, compared to year-ago quarter EPS of $0.30. The stock has a 52-week-high of 118.939 and a 52-week-low of 17.18. At the end of the last trading period, Enphase Energy closed at $98.63.
For Enphase Energy Inc (NASDAQ:ENPH), HC Wainwright & Co. downgraded the previous rating of Buy to the current rating Neutral. For the third quarter, Enphase Energy had an EPS of $0.30, compared to year-ago quarter EPS of $0.30. The current stock performance of Enphase Energy shows a 52-week-high of 118.939 and a 52-week-low of 17.18. Moreover, at the end of the last trading period, the closing price was at $98.63.
According to Goldman Sachs, the prior rating for Relmada Therapeutics Inc (NASDAQ:RLMD) was changed from Buy to Neutral. At the moment, the stock has a 52-week-high of 54.0 and a 52-week-low of 21.85. Relmada Therapeutics closed at $33.06 at the end of the last trading period.
For Exact Sciences Corp (NASDAQ:EXAS), Citigroup downgraded the previous rating of Buy to the current rating Neutral. In the third quarter, Exact Sciences showed an EPS of $0.07, compared to $0.31 from the year-ago quarter. The current stock performance of Exact Sciences shows a 52-week-high of 141.9 and a 52-week-low of 35.2512. Moreover, at the end of the last trading period, the closing price was at $131.12.
For Everbridge Inc (NASDAQ:EVBG), B of A Securities downgraded the previous rating of Buy to the current rating Neutral. In the second quarter, Everbridge showed an EPS of $0.06, compared to $0.07 from the year-ago quarter. The current stock performance of Everbridge shows a 52-week-high of 165.79 and a 52-week-low of 66.19. Moreover, at the end of the last trading period, the closing price was at $128.68.
For Armstrong World Industries Inc (NYSE:AWI), B of A Securities downgraded the previous rating of Buy to the current rating Neutral. The stock has a 52-week-high of 111.46 and a 52-week-low of 61.56. At the end of the last trading period, Armstrong World Indus closed at $62.91.
According to Stifel, the prior rating for New Fortress Energy Inc (NASDAQ:NFE) was changed from Buy to Hold. New Fortress Energy earned $0.24 in the second quarter, compared to $0.28 in the year-ago quarter. At the moment, the stock has a 52-week-high of 54.92 and a 52-week-low of 7.01. New Fortress Energy closed at $49.16 at the end of the last trading period.
According to Morgan Stanley, the prior rating for Harley-Davidson Inc (NYSE:HOG) was changed from Overweight to Equal-Weight. The stock has a 52-week-high of 40.86 and a 52-week-low of 14.31. At the end of the last trading period, Harley-Davidson closed at $35.37.
Evercore ISI Group downgraded the previous rating for Frontline Ltd (NYSE:FRO) from In-Line to Underperform. Frontline earned $1.04 in the second quarter, compared to $0.02 in the year-ago quarter. At the moment, the stock has a 52-week-high of 13.33 and a 52-week-low of 5.98. Frontline closed at $6.04 at the end of the last trading period.
According to JP Morgan, the prior rating for FB Financial Corp (NYSE:FBK) was changed from Neutral to Underweight. In the third quarter, FB Financial earned $1.46. At the moment, the stock has a 52-week-high of 40.33 and a 52-week-low of 14.38. FB Financial closed at $28.65 at the end of the last trading period.
Barclays downgraded the previous rating for Diamondback Energy Inc (NASDAQ:FANG) from Overweight to Equal-Weight. Diamondback Energy earned $0.15 in the second quarter, compared to $2.11 in the year-ago quarter. The stock has a 52-week-high of 96.92 and a 52-week-low of 14.55. At the end of the last trading period, Diamondback Energy closed at $26.57.
For DTE Energy Co (NYSE:DTE), BMO Capital downgraded the previous rating of Outperform to the current rating Market Perform. In the third quarter, DTE Energy showed an EPS of $2.61, compared to $1.91 from the year-ago quarter. At the moment, the stock has a 52-week-high of 135.67 and a 52-week-low of 71.21. DTE Energy closed at $127.25 at the end of the last trading period.
According to Credit Suisse, the prior rating for Veoneer Inc (NYSE:VNE) was changed from Neutral to Underperform. In the third quarter, Veoneer showed an EPS of $0.96, compared to $1.20 from the year-ago quarter. The stock has a 52-week-high of 18.9 and a 52-week-low of 5.25. At the end of the last trading period, Veoneer closed at $15.83.
For Varian Medical Systems Inc (NYSE:VAR), Baird downgraded the previous rating of Outperform to the current rating Neutral. For the fourth quarter, Varian Medical Systems had an EPS of $1.12, compared to year-ago quarter EPS of $1.21. The stock has a 52-week-high of 176.19 and a 52-week-low of 89.62. At the end of the last trading period, Varian Medical Systems closed at $173.02.
According to Piper Sandler, the prior rating for Livongo Health Inc (NASDAQ:LVGO) was changed from Overweight to Neutral. For the third quarter, Livongo Health had an EPS of No EPS Value , compared to year-ago quarter EPS of $0.05. At the moment, the stock has a 52-week-high of 151.049 and a 52-week-low of 18.76. Livongo Health closed at $142.89 at the end of the last trading period.

Initiations

UBS initiated coverage on Vertex Pharmaceuticals Inc (NASDAQ:VRTX) with a Buy rating. The price target for Vertex Pharmaceuticals is set to $287.00. Vertex Pharmaceuticals earned $2.61 in the second quarter, compared to $1.26 in the year-ago quarter. At the moment, the stock has a 52-week-high of 306.08 and a 52-week-low of 192.32. Vertex Pharmaceuticals closed at $212.19 at the end of the last trading period.
With a current rating of Buy, Berenberg initiated coverage on Terreno Realty Corp (NYSE:TRNO). The price target seems to have been set at $70.00 for Terreno Realty. Terreno Realty earned $0.19 in the second quarter, compared to $0.33 in the year-ago quarter. At the moment, the stock has a 52-week-high of 64.24 and a 52-week-low of 42.115. Terreno Realty closed at $58.25 at the end of the last trading period.
UBS initiated coverage on Sarepta Therapeutics Inc (NASDAQ:SRPT) with a Buy rating. The price target for Sarepta Therapeutics is set to $212.00. For the second quarter, Sarepta Therapeutics had an EPS of $1.51, compared to year-ago quarter EPS of $0.83. At the moment, the stock has a 52-week-high of 175.0 and a 52-week-low of 78.06. Sarepta Therapeutics closed at $139.62 at the end of the last trading period.
Berenberg initiated coverage on Rexford Industrial Realty Inc (NYSE:REXR) with a Buy rating. The price target for Rexford Industrial Realty is set to $56.00. For the third quarter, Rexford Industrial Realty had an EPS of $0.33, compared to year-ago quarter EPS of $0.31. At the moment, the stock has a 52-week-high of 53.48 and a 52-week-low of 31.7871. Rexford Industrial Realty closed at $47.69 at the end of the last trading period.
With a current rating of Buy, Berenberg initiated coverage on Plymouth Industrial REIT Inc (NYSE:PLYM). The price target seems to have been set at $15.00 for Plymouth Industrial REIT. Plymouth Industrial REIT earned $0.45 in the second quarter, compared to $0.43 in the year-ago quarter. At the moment, the stock has a 52-week-high of 21.4964 and a 52-week-low of 7.79. Plymouth Industrial REIT closed at $12.75 at the end of the last trading period.
UBS initiated coverage on PTC Therapeutics Inc (NASDAQ:PTCT) with a Neutral rating. The price target for PTC Therapeutics is set to $55.00. PTC Therapeutics earned $2.62 in the second quarter, compared to $0.75 in the year-ago quarter. The current stock performance of PTC Therapeutics shows a 52-week-high of 59.89 and a 52-week-low of 30.7923. Moreover, at the end of the last trading period, the closing price was at $53.26.
Berenberg initiated coverage on Monmouth Real Estate Investment Corp (NYSE:MNR) with a Buy rating. The price target for Monmouth Real Estate Inv is set to $17.00. For the third quarter, Monmouth Real Estate Inv had an EPS of $0.20, compared to year-ago quarter EPS of $0.21. The stock has a 52-week-high of 15.53 and a 52-week-low of 8.42. At the end of the last trading period, Monmouth Real Estate Inv closed at $14.22.
With a current rating of Buy, UBS initiated coverage on Immunovant Inc (NASDAQ:IMVT). The price target seems to have been set at $61.00 for Immunovant. Immunovant earned $0.38 in the first quarter. The current stock performance of Immunovant shows a 52-week-high of 43.9399 and a 52-week-low of 8.34. Moreover, at the end of the last trading period, the closing price was at $42.93.
With a current rating of Neutral, UBS initiated coverage on Gilead Sciences Inc (NASDAQ:GILD). The price target seems to have been set at $61.00 for Gilead Sciences. Gilead Sciences earned No EPS Value in the third quarter, compared to $1.75 in the year-ago quarter. The current stock performance of Gilead Sciences shows a 52-week-high of 85.97 and a 52-week-low of 59.395. Moreover, at the end of the last trading period, the closing price was at $60.01.
With a current rating of Buy, B of A Securities initiated coverage on Cal-Maine Foods Inc (NASDAQ:CALM). The price target seems to have been set at $47.00 for Cal-Maine Foods. In the first quarter, Cal-Maine Foods showed an EPS of $0.40, compared to $0.94 from the year-ago quarter. At the moment, the stock has a 52-week-high of 46.6576 and a 52-week-low of 30.74. Cal-Maine Foods closed at $38.87 at the end of the last trading period.
With a current rating of Neutral, UBS initiated coverage on Biogen Inc (NASDAQ:BIIB). The price target seems to have been set at $268.00 for Biogen. Biogen earned $8.84 in the third quarter, compared to $9.17 in the year-ago quarter. The current stock performance of Biogen shows a 52-week-high of 374.99 and a 52-week-low of 254.925. Moreover, at the end of the last trading period, the closing price was at $255.30.
With a current rating of Neutral, UBS initiated coverage on Amgen Inc (NASDAQ:AMGN). The price target seems to have been set at $232.00 for Amgen. Amgen earned No EPS Value in the third quarter, compared to $3.66 in the year-ago quarter. The stock has a 52-week-high of 264.97 and a 52-week-low of 177.05. At the end of the last trading period, Amgen closed at $223.46.
With a current rating of Neutral, UBS initiated coverage on Alexion Pharmaceuticals Inc (NASDAQ:ALXN). The price target seems to have been set at $133.00 for Alexion Pharmaceuticals. In the second quarter, Alexion Pharmaceuticals showed an EPS of $3.11, compared to $2.64 from the year-ago quarter. The current stock performance of Alexion Pharmaceuticals shows a 52-week-high of 128.57 and a 52-week-low of 72.67. Moreover, at the end of the last trading period, the closing price was at $120.00.
With a current rating of Neutral, JP Morgan initiated coverage on Hyliion Holdings Corp (NYSE:HYLN). The price target seems to have been set at $27.00 for Hyliion Holdings. The stock has a 52-week-high of 44.9 and a 52-week-low of 20.4. At the end of the last trading period, Hyliion Holdings closed at $21.31.
Jefferies initiated coverage on Burlington Stores Inc (NYSE:BURL) with a Buy rating. The price target for Burlington Stores is set to $255.00. In the second quarter, Burlington Stores showed an EPS of $0.56, compared to $1.36 from the year-ago quarter. The stock has a 52-week-high of 250.89 and a 52-week-low of 105.67. At the end of the last trading period, Burlington Stores closed at $200.18.

Upgrades

升級

For Omnicom Group Inc (NYSE:OMC), MoffettNathanson upgraded the previous rating of Sell to the current rating Neutral. Omnicom Group earned $1.21 in the third quarter, compared to $1.32 in the year-ago quarter. At the moment, the stock has a 52-week-high of 82.73 and a 52-week-low of 46.37. Omnicom Group closed at $48.81 at the end of the last trading period.
For Advanced Micro Devices Inc (NASDAQ:AMD), Craig-Hallum upgraded the previous rating of Hold to the current rating Buy. For the third quarter, Advanced Micro Devices had an EPS of $0.41, compared to year-ago quarter EPS of $0.18. At the moment, the stock has a 52-week-high of 94.28 and a 52-week-low of 31.83. Advanced Micro Devices closed at $78.88 at the end of the last trading period.
B. Riley FBR upgraded the previous rating for ViewRay Inc (NASDAQ:VRAY) from Neutral to Buy. For the second quarter, ViewRay had an EPS of $0.18, compared to year-ago quarter EPS of $0.32. The current stock performance of ViewRay shows a 52-week-high of 4.88 and a 52-week-low of 1.1055. Moreover, at the end of the last trading period, the closing price was at $3.00.
Deutsche Bank upgraded the previous rating for Lululemon Athletica Inc (NASDAQ:LULU) from Hold to Buy. For the second quarter, Lululemon Athletica had an EPS of $0.74, compared to year-ago quarter EPS of $0.96. The stock has a 52-week-high of 399.8965 and a 52-week-low of 128.845. At the end of the last trading period, Lululemon Athletica closed at $333.81.
According to JP Morgan, the prior rating for Xilinx Inc (NASDAQ:XLNX) was changed from Underweight to Neutral. Xilinx earned $0.79 in the second quarter, compared to $0.94 in the year-ago quarter. The stock has a 52-week-high of 130.4 and a 52-week-low of 67.68. At the end of the last trading period, Xilinx closed at $124.35.
JP Morgan upgraded the previous rating for Sherwin-Williams Co (NYSE:SHW) from Neutral to Overweight. In the third quarter, Sherwin-Williams showed an EPS of $8.29, compared to $6.65 from the year-ago quarter. The current stock performance of Sherwin-Williams shows a 52-week-high of 725.91 and a 52-week-low of 325.43. Moreover, at the end of the last trading period, the closing price was at $673.04.
For MSC Industrial Direct Co Inc (NYSE:MSM), Raymond James upgraded the previous rating of Underperform to the current rating Market Perform. In the fourth quarter, MSC Industrial Direct Co showed an EPS of $1.09, compared to $1.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of 79.87 and a 52-week-low of 44.93. MSC Industrial Direct Co closed at $67.72 at the end of the last trading period.
Barclays upgraded the previous rating for First Solar Inc (NASDAQ:FSLR) from Underweight to Equal-Weight. First Solar earned $1.45 in the third quarter, compared to $0.29 in the year-ago quarter. The stock has a 52-week-high of 87.44 and a 52-week-low of 28.47. At the end of the last trading period, First Solar closed at $82.39.
For Advanced Micro Devices Inc (NASDAQ:AMD), Barclays upgraded the previous rating of Equal-Weight to the current rating Overweight. For the third quarter, Advanced Micro Devices had an EPS of $0.41, compared to year-ago quarter EPS of $0.18. The current stock performance of Advanced Micro Devices shows a 52-week-high of 94.28 and a 52-week-low of 31.83. Moreover, at the end of the last trading period, the closing price was at $78.88.
According to Keefe, Bruyette & Woods, the prior rating for Invesco Ltd (NYSE:IVZ) was changed from Market Perform to Outperform. For the third quarter, Invesco had an EPS of $0.53, compared to year-ago quarter EPS of $0.70. The stock has a 52-week-high of 19.01 and a 52-week-low of 6.375. At the end of the last trading period, Invesco closed at $13.96.

為宏盟集團(Omnicom Group Inc.)紐約證券交易所代碼：OMC)，MoffettNathanson將之前的評級上調為賣出，目前評級為中性。宏盟集團第三季度盈利1.21美元，而去年同期為1.32美元。目前，該股的52周高點為82.73，52周低點為46.37。宏盟集團上交易期尾盤收報48.81美元。
為先進微設備公司(納斯達克：AMD)，Craig-Hallum將之前的評級為持有上調至當前評級買入。第三季度，Advanced Micro Devices的每股收益為0.41美元，而去年同期為0.18美元。目前，該股的52周高點為94.28，52周低點為31.83。Advanced Micro Devices上一交易期尾盤收報78.88美元。
B.Riley FBR上調了之前的評級ViewRay Inc.(納斯達克：弗雷)從中性到買入。第二季度，ViewRay的每股收益為0.18美元，而去年同期為0.32美元。目前ViewRay的股票表現顯示，52周高點為4.88%，52周低點為1.1055。而且，在上個交易期結束時，收盤價為3.00美元。
德意志銀行上調之前的評級為露露檸檬運動公司(納斯達克：露露)從持有到買入。第二季度，露露檸檬運動公司的每股收益為0.74美元，而去年同期為0.96美元。該股的52周高點為399.8965，52周低點為128.845。上交易期尾盤，露露檸檬競技股收報333.81美元。
根據摩根大通(JP Morgan)的説法，之前的評級為Xilinx Inc.(納斯達克：XLNX)從減持改為中性。Xilinx第二季度的利潤為0.79美元，而去年同期為0.94美元。該股的52周高點為130.4，52周低點為67.68.上交易期尾盤，Xilinx收報124.35美元。
摩根大通上調了之前的評級，舍温-威廉姆斯公司紐約證券交易所代碼：Shw)從中性到超重。舍温-威廉姆斯第三季度每股收益為8.29美元，而去年同期為6.65美元。舍温-威廉姆斯目前的股票表現顯示，52周高點為725.91，52周低點為325.43。而且，在上個交易期結束時，收盤價為673.04美元。
為MSC工業直接公司紐約證券交易所代碼：男男性接觸者)，Raymond James將之前對UnderPerformance的評級上調至當前評級市場表現。MSC Industrial Direct Co第四季EPS為1.09美元，上年同期為1.30美元.目前，該股的52周高點為79.87，52周低點為44.93。MSC Industrial Direct Co上一交易期尾盤收報67.72美元。
巴克萊上調了之前的評級為第一太陽能公司(納斯達克：FSLR從體重不足到體重相等。First Solar第三季度盈利1.45美元，而去年同期為0.29美元。該股的52周高點為87.44，52周低點為28.47。上交易期尾盤，First Solar收報82.39美元。
為先進微設備公司(納斯達克：AMD)，巴克萊將之前的評級上調為等權重至當前評級加碼。第三季度，Advanced Micro Devices的每股收益為0.41美元，而去年同期為0.18美元。目前Advanced Micro Devices的股票表現顯示52周高點為94.28，52周低點為31.83。而且，在上個交易期結束時，收盤價為78.88美元。
根據Keefe，Bruyette&Woods的説法，之前的評級為景順有限公司紐約證券交易所代碼：IVZ)從市場表現改為跑贏大盤。第三季度，景順的每股收益為0.53美元，而去年同期為0.70美元。該股的52周高點為19.01點，52周低點為6.375點。上一交易期尾盤，景順收報13.96美元。

Downgrades

降級

According to Craig-Hallum, the prior rating for Enphase Energy Inc (NASDAQ:ENPH) was changed from Buy to Hold. For the third quarter, Enphase Energy had an EPS of $0.30, compared to year-ago quarter EPS of $0.30. The stock has a 52-week-high of 118.939 and a 52-week-low of 17.18. At the end of the last trading period, Enphase Energy closed at $98.63.
For Enphase Energy Inc (NASDAQ:ENPH), HC Wainwright & Co. downgraded the previous rating of Buy to the current rating Neutral. For the third quarter, Enphase Energy had an EPS of $0.30, compared to year-ago quarter EPS of $0.30. The current stock performance of Enphase Energy shows a 52-week-high of 118.939 and a 52-week-low of 17.18. Moreover, at the end of the last trading period, the closing price was at $98.63.
According to Goldman Sachs, the prior rating for Relmada Therapeutics Inc (NASDAQ:RLMD) was changed from Buy to Neutral. At the moment, the stock has a 52-week-high of 54.0 and a 52-week-low of 21.85. Relmada Therapeutics closed at $33.06 at the end of the last trading period.
For Exact Sciences Corp (NASDAQ:EXAS), Citigroup downgraded the previous rating of Buy to the current rating Neutral. In the third quarter, Exact Sciences showed an EPS of $0.07, compared to $0.31 from the year-ago quarter. The current stock performance of Exact Sciences shows a 52-week-high of 141.9 and a 52-week-low of 35.2512. Moreover, at the end of the last trading period, the closing price was at $131.12.
For Everbridge Inc (NASDAQ:EVBG), B of A Securities downgraded the previous rating of Buy to the current rating Neutral. In the second quarter, Everbridge showed an EPS of $0.06, compared to $0.07 from the year-ago quarter. The current stock performance of Everbridge shows a 52-week-high of 165.79 and a 52-week-low of 66.19. Moreover, at the end of the last trading period, the closing price was at $128.68.
For Armstrong World Industries Inc (NYSE:AWI), B of A Securities downgraded the previous rating of Buy to the current rating Neutral. The stock has a 52-week-high of 111.46 and a 52-week-low of 61.56. At the end of the last trading period, Armstrong World Indus closed at $62.91.
According to Stifel, the prior rating for New Fortress Energy Inc (NASDAQ:NFE) was changed from Buy to Hold. New Fortress Energy earned $0.24 in the second quarter, compared to $0.28 in the year-ago quarter. At the moment, the stock has a 52-week-high of 54.92 and a 52-week-low of 7.01. New Fortress Energy closed at $49.16 at the end of the last trading period.
According to Morgan Stanley, the prior rating for Harley-Davidson Inc (NYSE:HOG) was changed from Overweight to Equal-Weight. The stock has a 52-week-high of 40.86 and a 52-week-low of 14.31. At the end of the last trading period, Harley-Davidson closed at $35.37.
Evercore ISI Group downgraded the previous rating for Frontline Ltd (NYSE:FRO) from In-Line to Underperform. Frontline earned $1.04 in the second quarter, compared to $0.02 in the year-ago quarter. At the moment, the stock has a 52-week-high of 13.33 and a 52-week-low of 5.98. Frontline closed at $6.04 at the end of the last trading period.
According to JP Morgan, the prior rating for FB Financial Corp (NYSE:FBK) was changed from Neutral to Underweight. In the third quarter, FB Financial earned $1.46. At the moment, the stock has a 52-week-high of 40.33 and a 52-week-low of 14.38. FB Financial closed at $28.65 at the end of the last trading period.
Barclays downgraded the previous rating for Diamondback Energy Inc (NASDAQ:FANG) from Overweight to Equal-Weight. Diamondback Energy earned $0.15 in the second quarter, compared to $2.11 in the year-ago quarter. The stock has a 52-week-high of 96.92 and a 52-week-low of 14.55. At the end of the last trading period, Diamondback Energy closed at $26.57.
For DTE Energy Co (NYSE:DTE), BMO Capital downgraded the previous rating of Outperform to the current rating Market Perform. In the third quarter, DTE Energy showed an EPS of $2.61, compared to $1.91 from the year-ago quarter. At the moment, the stock has a 52-week-high of 135.67 and a 52-week-low of 71.21. DTE Energy closed at $127.25 at the end of the last trading period.
According to Credit Suisse, the prior rating for Veoneer Inc (NYSE:VNE) was changed from Neutral to Underperform. In the third quarter, Veoneer showed an EPS of $0.96, compared to $1.20 from the year-ago quarter. The stock has a 52-week-high of 18.9 and a 52-week-low of 5.25. At the end of the last trading period, Veoneer closed at $15.83.
For Varian Medical Systems Inc (NYSE:VAR), Baird downgraded the previous rating of Outperform to the current rating Neutral. For the fourth quarter, Varian Medical Systems had an EPS of $1.12, compared to year-ago quarter EPS of $1.21. The stock has a 52-week-high of 176.19 and a 52-week-low of 89.62. At the end of the last trading period, Varian Medical Systems closed at $173.02.
According to Piper Sandler, the prior rating for Livongo Health Inc (NASDAQ:LVGO) was changed from Overweight to Neutral. For the third quarter, Livongo Health had an EPS of No EPS Value , compared to year-ago quarter EPS of $0.05. At the moment, the stock has a 52-week-high of 151.049 and a 52-week-low of 18.76. Livongo Health closed at $142.89 at the end of the last trading period.

根據克雷格-哈勒姆(Craig-Hallum)的説法，之前的評級為恩相能源公司(納斯達克：ENPH)已從買入更改為持有。第三季度，恩相能源公司的每股收益為0.30美元，而去年同期為0.30美元。該股的52周高點為118.939，52周低點為17.18.上一交易期尾盤，恩相能源收報98.63美元。
為恩相能源公司(納斯達克：ENPH)，HC Wainwright&Co.將之前對買入的評級下調至當前評級中性。第三季度，恩相能源公司的每股收益為0.30美元，而去年同期為0.30美元。恩相能源目前的股票表現顯示，52周高點為118.939，52周低點為17.18.而且，在上個交易期結束時，收盤價為98.63美元。
根據高盛(Goldman Sachs)的説法，之前的評級為Relmada治療公司(納斯達克：RLMD)從買入改為中性。目前，該股的52周高點為54.0，52周低點為21.85。Relmada Treeutics上一交易期尾盤報33.06美元。
為精密科學公司(納斯達克：EXAS)，花旗將之前對買入的評級下調至當前評級中性。第三季度，Exact Sciences顯示每股收益為0.07美元，而去年同期為0.31美元。精密科學目前的股票表現顯示，52周高點為141.9，52周低點為35.2512。而且，在上個交易期結束時，收盤價為131.12美元。
為Everbridge Inc.(納斯達克：EVBG)，B of A Securities將之前的買入評級下調至當前評級中性。第二季度，Everbridge的每股收益為0.06美元，而去年同期為0.07美元。目前長橋的股票表現顯示，52周高點為165.79，52周低點為66.19.而且，在上個交易期結束時，收盤價為128.68美元。
為阿姆斯特朗世界工業公司紐約證券交易所代碼：AWI)，B of A Securities將之前的買入評級下調至當前評級中性。該股的52周高點為111.46，52周低點為61.56.阿姆斯特朗世界印度河股票上一交易期尾盤報62.91美元。
根據Stifel的説法，之前的評級為新堡壘能源公司(納斯達克：NFE)已從買入更改為持有。新堡壘能源公司第二季度盈利0.24美元，而去年同期為0.28美元。目前，該股的52周高點為54.92，52周低點為7.01。新堡壘能源上交易期尾盤收報49.16美元。
據摩根士丹利(Morgan Stanley)稱，之前的評級為哈雷-戴維森公司紐約證券交易所代碼：小豬)從超重改為等重。該股的52周高點為40.86，52周低點為14.31。上一交易期尾盤，哈雷戴維森收報35.37美元。
Evercore ISI Group下調之前的評級為前線有限公司紐約證券交易所代碼：從前)從In-Line(在線)到UnderPerformance(未完成)。Frontline第二季度的利潤為1.04美元，而去年同期為0.02美元。目前，該股的52周高點為13.33，52周低點為5.98。前線上一交易期尾盤報6.04美元。
根據摩根大通(JP Morgan)的説法，之前的評級為FB金融公司紐約證券交易所代碼：FBK)由中性改為減重。第三季度，FB Financial的利潤為1.46美元。目前，該股的52周高點為40.33，52周低點為14.38。FB Financial上交易日尾盤報28.65美元。
巴克萊下調之前的評級為響尾蛇能源公司(納斯達克：方從超重到等重。響尾蛇能源第二季度盈利0.15美元，而去年同期為2.11美元。該股的52周高點為96.92，52周低點為14.55。上一交易期尾盤，響尾蛇能源收報26.57美元。
為DTE能源公司紐約證券交易所代碼：DTE)，BMO Capital將之前評級為表現優於大盤下調至當前評級市場表現。第三季度，DTE Energy顯示每股收益為2.61美元，而去年同期為1.91美元。目前該股的52周高點為135.67，52周低點為71.21.東興能源上交易期尾盤收報127.25美元。
根據瑞士信貸(Credit Suisse)的説法，之前的評級為Veoneer Inc.紐約證券交易所代碼：VNE)已從中性更改為表現不佳。第三季度，Veoneer顯示每股收益為0.96美元，而去年同期為1.20美元。該股的52周高點為18.9，52周低點為5.25。上個交易期尾盤，Veoneer收報15.83美元。
為瓦里安醫療系統公司紐約證券交易所代碼：變量)，Baird將之前的評級下調至跑贏大盤，至當前評級中性。第四季度，瓦里安醫療系統公司的每股收益為1.12美元，而去年同期為1.21美元。該股的52周高點為176.19，52周低點為89.62.上個交易期尾盤，瓦里安醫療系統公司收報173.02美元。
根據派珀·桑德勒(Piper Sandler)的説法，之前的評級為Livongo Health Inc.(納斯達克：LVGO)由增持改為中性。第三季度，Livongo Health的每股收益為無EPS值，而去年同期每股收益為0.05美元。目前，該股的52周高點為151.049，52周低點為18.76.Livongo Health上一交易期尾盤報142.89美元。

Initiations

啟蒙行動

UBS initiated coverage on Vertex Pharmaceuticals Inc (NASDAQ:VRTX) with a Buy rating. The price target for Vertex Pharmaceuticals is set to $287.00. Vertex Pharmaceuticals earned $2.61 in the second quarter, compared to $1.26 in the year-ago quarter. At the moment, the stock has a 52-week-high of 306.08 and a 52-week-low of 192.32. Vertex Pharmaceuticals closed at $212.19 at the end of the last trading period.
With a current rating of Buy, Berenberg initiated coverage on Terreno Realty Corp (NYSE:TRNO). The price target seems to have been set at $70.00 for Terreno Realty. Terreno Realty earned $0.19 in the second quarter, compared to $0.33 in the year-ago quarter. At the moment, the stock has a 52-week-high of 64.24 and a 52-week-low of 42.115. Terreno Realty closed at $58.25 at the end of the last trading period.
UBS initiated coverage on Sarepta Therapeutics Inc (NASDAQ:SRPT) with a Buy rating. The price target for Sarepta Therapeutics is set to $212.00. For the second quarter, Sarepta Therapeutics had an EPS of $1.51, compared to year-ago quarter EPS of $0.83. At the moment, the stock has a 52-week-high of 175.0 and a 52-week-low of 78.06. Sarepta Therapeutics closed at $139.62 at the end of the last trading period.
Berenberg initiated coverage on Rexford Industrial Realty Inc (NYSE:REXR) with a Buy rating. The price target for Rexford Industrial Realty is set to $56.00. For the third quarter, Rexford Industrial Realty had an EPS of $0.33, compared to year-ago quarter EPS of $0.31. At the moment, the stock has a 52-week-high of 53.48 and a 52-week-low of 31.7871. Rexford Industrial Realty closed at $47.69 at the end of the last trading period.
With a current rating of Buy, Berenberg initiated coverage on Plymouth Industrial REIT Inc (NYSE:PLYM). The price target seems to have been set at $15.00 for Plymouth Industrial REIT. Plymouth Industrial REIT earned $0.45 in the second quarter, compared to $0.43 in the year-ago quarter. At the moment, the stock has a 52-week-high of 21.4964 and a 52-week-low of 7.79. Plymouth Industrial REIT closed at $12.75 at the end of the last trading period.
UBS initiated coverage on PTC Therapeutics Inc (NASDAQ:PTCT) with a Neutral rating. The price target for PTC Therapeutics is set to $55.00. PTC Therapeutics earned $2.62 in the second quarter, compared to $0.75 in the year-ago quarter. The current stock performance of PTC Therapeutics shows a 52-week-high of 59.89 and a 52-week-low of 30.7923. Moreover, at the end of the last trading period, the closing price was at $53.26.
Berenberg initiated coverage on Monmouth Real Estate Investment Corp (NYSE:MNR) with a Buy rating. The price target for Monmouth Real Estate Inv is set to $17.00. For the third quarter, Monmouth Real Estate Inv had an EPS of $0.20, compared to year-ago quarter EPS of $0.21. The stock has a 52-week-high of 15.53 and a 52-week-low of 8.42. At the end of the last trading period, Monmouth Real Estate Inv closed at $14.22.
With a current rating of Buy, UBS initiated coverage on Immunovant Inc (NASDAQ:IMVT). The price target seems to have been set at $61.00 for Immunovant. Immunovant earned $0.38 in the first quarter. The current stock performance of Immunovant shows a 52-week-high of 43.9399 and a 52-week-low of 8.34. Moreover, at the end of the last trading period, the closing price was at $42.93.
With a current rating of Neutral, UBS initiated coverage on Gilead Sciences Inc (NASDAQ:GILD). The price target seems to have been set at $61.00 for Gilead Sciences. Gilead Sciences earned No EPS Value in the third quarter, compared to $1.75 in the year-ago quarter. The current stock performance of Gilead Sciences shows a 52-week-high of 85.97 and a 52-week-low of 59.395. Moreover, at the end of the last trading period, the closing price was at $60.01.
With a current rating of Buy, B of A Securities initiated coverage on Cal-Maine Foods Inc (NASDAQ:CALM). The price target seems to have been set at $47.00 for Cal-Maine Foods. In the first quarter, Cal-Maine Foods showed an EPS of $0.40, compared to $0.94 from the year-ago quarter. At the moment, the stock has a 52-week-high of 46.6576 and a 52-week-low of 30.74. Cal-Maine Foods closed at $38.87 at the end of the last trading period.
With a current rating of Neutral, UBS initiated coverage on Biogen Inc (NASDAQ:BIIB). The price target seems to have been set at $268.00 for Biogen. Biogen earned $8.84 in the third quarter, compared to $9.17 in the year-ago quarter. The current stock performance of Biogen shows a 52-week-high of 374.99 and a 52-week-low of 254.925. Moreover, at the end of the last trading period, the closing price was at $255.30.
With a current rating of Neutral, UBS initiated coverage on Amgen Inc (NASDAQ:AMGN). The price target seems to have been set at $232.00 for Amgen. Amgen earned No EPS Value in the third quarter, compared to $3.66 in the year-ago quarter. The stock has a 52-week-high of 264.97 and a 52-week-low of 177.05. At the end of the last trading period, Amgen closed at $223.46.
With a current rating of Neutral, UBS initiated coverage on Alexion Pharmaceuticals Inc (NASDAQ:ALXN). The price target seems to have been set at $133.00 for Alexion Pharmaceuticals. In the second quarter, Alexion Pharmaceuticals showed an EPS of $3.11, compared to $2.64 from the year-ago quarter. The current stock performance of Alexion Pharmaceuticals shows a 52-week-high of 128.57 and a 52-week-low of 72.67. Moreover, at the end of the last trading period, the closing price was at $120.00.
With a current rating of Neutral, JP Morgan initiated coverage on Hyliion Holdings Corp (NYSE:HYLN). The price target seems to have been set at $27.00 for Hyliion Holdings. The stock has a 52-week-high of 44.9 and a 52-week-low of 20.4. At the end of the last trading period, Hyliion Holdings closed at $21.31.
Jefferies initiated coverage on Burlington Stores Inc (NYSE:BURL) with a Buy rating. The price target for Burlington Stores is set to $255.00. In the second quarter, Burlington Stores showed an EPS of $0.56, compared to $1.36 from the year-ago quarter. The stock has a 52-week-high of 250.89 and a 52-week-low of 105.67. At the end of the last trading period, Burlington Stores closed at $200.18.

瑞銀在Vertex製藥公司(納斯達克：VRTX)，評級為買入。Vertex PharmPharmticals的目標價定為287.00美元。Vertex製藥公司第二季度的利潤為2.61美元，而去年同期為1.26美元。目前，該股的52周高點為306.08，52周低點為192.32。Vertex PharmPharmticals上一交易期尾盤報212.19美元。
目前評級為買入，貝倫伯格在特雷諾房地產公司紐約證券交易所代碼：TRNO)。Terreno Realty的目標價似乎被設定在70.00美元。Terreno Realty第二季度盈利0.19美元，而去年同期為0.33美元。目前，該股的52周高點為64.24點，52周低點為42.115點。Terreno Realty上一交易期尾盤報58.25美元。
瑞銀在Sarepta治療公司(納斯達克：SRPT)，評級為買入。薩雷普塔治療公司的目標價格定為212.00美元。第二季度，Sarepta治療公司的每股收益為1.51美元，而去年同期為0.83美元。目前該股的52周高點為175.0，52周低點為78.06.賽瑞普塔治療公司上一交易期尾盤收報139.62美元。
貝倫伯格發起了關於雷克斯福德工業地產公司紐約證券交易所代碼：REXR)，評級為買入。雷克斯福德工業地產(Rexford Industrial Realty)的目標價定為56.00美元。第三季度，雷克斯福德工業地產(Rexford Industrial Realty)的每股收益為0.33美元，而去年同期為0.31美元。目前，該股的52周高點為53.48點，52周低點為31.7871點。Rexford Industrial Realty上一交易期尾盤報47.69美元。
目前評級為買入，貝倫伯格在普利茅斯工業房地產投資信託基金公司紐約證券交易所代碼：摺疊機)。普利茅斯工業房地產投資信託基金的目標價似乎被設定在15.00美元。普利茅斯工業房地產投資信託基金第二季度盈利0.45美元，而去年同期為0.43美元。目前該股的52周高點為21.4964，52周低點為7.79.普利茅斯工業房地產投資信託基金上一交易期尾盤報12.75美元。
瑞銀在PTC治療公司(納斯達克：PTCT)，評級為中性。PTC治療公司的目標價定為55.00美元。PTC治療公司第二季度的利潤為2.62美元，而去年同期為0.75美元。PTC治療公司目前的股票表現顯示，52周高點為59.89點，52周低點為30.7923點。而且，在上個交易期結束時，收盤價為53.26美元。
貝倫伯格發起了關於蒙茅斯房地產投資公司紐約證券交易所代碼：Mnr)，評級為買入。蒙茅斯房地產Inv的目標價定為17.00美元。第三季度，蒙茅斯房地產公司的每股收益為0.20美元，而去年同期為0.21美元。該股的52周高點為15.53，52周低點為8.42。上交易期尾盤，蒙茅斯地產Inv收報14.22美元。
在目前評級為買入的情況下，瑞銀在Immunovant Inc.(納斯達克：IMVT)。Immunovant的目標價格似乎被設定在61.00美元。Immunovant第一季度盈利0.38美元。目前Immunovant的股票表現顯示，52周高點為43.9399，52周低點為8.34.而且，在上個交易期結束時，收盤價為42.93美元。
在目前評級為中性的情況下，瑞銀在吉利德科學公司(納斯達克：鍍金)。吉利德科學公司的目標價似乎被設定在61.00美元。吉利德科學公司贏得了無EPS值第三季度為1.75美元，而去年同期為1.75美元。吉利德科學目前的股票表現顯示，52周高點為85.97%，52周低點為59.395。而且，在上個交易期結束時，收盤價為60.01美元。
在目前評級為買入的情況下，美國銀行證券在加州緬因州食品公司(Cal-Maine Foods Inc.)(納斯達克：平靜)。Cal-Maine Foods的目標價似乎被設定在47.00美元。第一季度，Cal-Maine Foods的每股收益為0.40美元，而去年同期為0.94美元。目前該股的52周高點為46.6576，52周低點為30.74.Cal-Maine Foods上一交易期尾盤報38.87美元。
在目前評級為中性的情況下，瑞銀在生物遺傳公司(納斯達克：BIIB)。生物遺傳公司的目標價格似乎被設定在268.00美元。Biogen第三季度盈利8.84美元，而去年同期為9.17美元。生物遺傳目前的股票表現顯示，52周高點為374.99，52周低點為254.925。而且，在上個交易期結束時，收盤價為255.30美元。
在目前評級為中性的情況下，瑞銀在安進公司(納斯達克：AMGN)。安進的目標價似乎被設定在232.00美元。安進贏得無EPS值第三季度為3.66美元，而去年同期為3.66美元。該股的52周高點為264.97，52周低點為177.05。上一交易期尾盤，安進收報223.46美元。
在目前評級為中性的情況下，瑞銀在Alexion製藥公司(納斯達克：ALXN)。亞歷克森製藥公司的目標價似乎被設定在133.00美元。第二季度，Alexion製藥公司的每股收益為3.11美元，而去年同期為2.64美元。Alexion PharmPharmticals目前的股票表現顯示，52周高點為128.57，52周低點為72.67.而且，在上個交易期結束時，收盤價為120.00美元。
目前評級為中性，摩根大通在海利安控股公司紐約證券交易所代碼：HYLN)。Hyliion Holdings的目標價似乎被設定在27.00美元。該股的52周高點為44.9，52周低點為20.4。上一交易期尾盤，Hyliion Holdings收報21.31美元。
Jefferies發起了關於伯靈頓百貨公司紐約證券交易所代碼：伯爾)，評級為買入。伯靈頓百貨的目標價定為255.00美元。第二季度，Burlington Stores的每股收益為0.56美元，而去年同期為1.36美元。該股的52周高點為250.89，52周低點為105.67。上一交易期尾盤，Burlington Stores收報200.18美元。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息

Benzinga's Top Upgrades, Downgrades For October 28, 2020

Benzinga's Top Upgrades, Downgrades For October 28, 2020

Upgrades

Downgrades

Initiations

Upgrades

升級

Downgrades

降級

Initiations

啟蒙行動

風險及免責聲明

聲明